Aptanomics is a privately-held biopharmaceutical company founded in 2001 to exploit technology developed at Massachusetts General Hospital and Harvard Medical S...
| Website | http://www.aptanomics.com |
| Revenue | $4.2 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2001 |
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Healthcare, Drug Discovery, Drug Manufacturing & Research |
| Keywords | Aptamer Therapeutics, Therapeutic Antibodies, Biopharmaceutical Research, Drug Development, Pharmaceutical Development, Clinical Trials, Biotechnology, Molecular Medicine, Targeted Therapies, Precision Medicine, Cancer Treatment, Immunotherapy, Protein Engineering, Drug Discovery, Pharmaceutical, Life Sciences, Biologics, Clinical Stage |
| Competitors | Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, Bristol Myers Squibb, Genentech, Amgen, Regeneron +40 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Aptanomics employee's phone or email?
Aptanomics Questions
The Aptanomics annual revenue was $4.2 million in 2026.
The NAICS codes for Aptanomics are [32, 3254, 32541, 325].
The SIC codes for Aptanomics are [283, 28, 2834].
Related Companies
G2Crowd Trusted
300K+
Plugin Users
